• Datametrex AI (DM) has announced that the 1copy™ COVID-19 qPCR Multi Kit (qPCR Kit) can detect the Omicron (B.1.1.529) variant
  • The qPCR kit is manufactured by 1drop Inc. in South Korea
  • Datametrex has the rights to sell the qPCR Kit
  • The qPCR kit is a nucleic test kit providing results in less than two hours
  • Datametrex AI is a technology focused company with exposure to AI and machine learning
  • Datametrex AI Ltd. (DM) opened trading at $0.185 per share

Datametrex AI (DM) has announced that the 1copy™ COVID-19 qPCR Multi Kit (qPCR Kit) can detect the Omicron (B.1.1.529) variant.

“The company continues to work with our suppliers to provide a reliable and safe product that our consumers can rely on. With the new mutations of the COVID-19 virus being discovered worldwide including the new highly contagious Omicron variant, management feels that persistent COVID-19 testing will be necessary for the near future as part of the answer to keep people secure and healthy,” said Andrew Ryu, Chairman of the Company.

The qPCR kit can detect COVID-19 regardless of the existence of SARS-CoV-2 variants and include the following variants:

  • UK variant (Alpha B.1.17)
  • South Africa variant (Beta P.1.351)
  • Brazil variant (Gamma P.1)
  • India variant (Delta B.1.617.2)
  • Columbia variant ( Mu B.1.621)

The qPCR Kit is a nucleic test kit providing results in less than two hours. 

1drop, located in Jungwon-gu, South Korea, was incorporated in 2017 following a technology spin-off from Samsung Electronic’s C-Lab program. 1drop has had more than five products approved in Europe in the past 18 months under the CE certification.

Datametrex’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for the COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis.

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex AI Ltd. (DM) opened trading at $0.185 per share.

More From The Market Online
stock market down

@ the Bell: TSX hits near-month high

The TSX rose near highs not seen in a month, but a split between indices capped gains as mining and energy were the only…

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

International Petroleum stock rallies on Q1 results

Canadian energy stock International Petroleum Corp. (TSX:IPCO) rose in Tuesday trading on its Q1 2024 financial...